Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient

Med J Aust. 2015 Mar 2;202(4):209-11. doi: 10.5694/mja14.00453.

Authors

David J Speers¹, Michael Xiang Ma², Helen M Faddy³, Monica Nash⁴, Scott Bowden⁵, Bastiaan de Boer⁶, Ross MacNicholas², Gerry MacQuillan², Leon Adams²

Affiliations

¹ PathWest Laboratory Medicine WA, Perth WA david.speers@health.wa.gov.au.
² Sir Charles Gairdner Hospital, Perth, WA, Australia.
³ Australian Red Cross Blood Service, Brisbane, QLD, Australia.
⁴ Australian Red Cross Blood Service, Sydney, NSW, Australia.
⁵ Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC, Australia.
⁶ PathWest Laboratory Medicine WA, Perth WA.

PMID: 25716605
DOI: 10.5694/mja14.00453

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Viral / analysis
Antiviral Agents / therapeutic use
Australia
End Stage Liver Disease / surgery*
Follow-Up Studies
Hepatitis E / drug therapy*
Hepatitis E / etiology
Hepatitis E / virology
Hepatitis E virus / genetics
Hepatitis E virus / immunology
Humans
Liver Transplantation*
Male
Middle Aged
RNA, Viral / analysis
Ribavirin / therapeutic use*
Transplant Recipients*

Substances

Antibodies, Viral
Antiviral Agents
RNA, Viral
Ribavirin